• High rate of persistent symptoms up to 4 months after community and hospital-managed SARS-CoV-2 infection 

      Darley, David R; Dore, Gregory J; Cysique, Lucette; Wilhelm, Kay A; Andresen, David; Tonga, Katrina; Stone, Emily; Byrne, Anthony; Plit, Marshall; Masters, Jeffrey; Tang, Helen; Brew, Bruce; Cunningham, Philip; Kelleher, Anthony; Matthews, Gail; Mistry, Sandeep G; Walker, Wallace; Earnshaw, James; Cervin, Anders; Gidding, Heather F; Machalek, Dorothy A; Hendry, Alexandra J; Quinn, Helen E; Vette, Kaitlyn; Beard, Frank H; Shilling, Hannah; Hirani, Rena; Gosbell, Ian B; Irving, David O; Hueston, Linda; Downes, Marnie; Carlin, John B; O'Sullivan, Matthew NV; Dwyer, Dominic E; Kaldor, John M; Macartney, Kristine; d'Emden, Michael C; Ungerer, Jacobus PJ; de Jersey, Susan J; Johnston, Kate; Tyson, Chloe; Danny, Indra; Meyer, Lois; Heriot, George S; Jamrozik, Euzebiusz; Way, Teagan L; Tarrant, Seth M; Balogh, Zsolt L; Stanaway, Fiona; Irwig, Les; Teixeira-Pinto, Armando; Bell, Katy J.L.; Horvath, Andrea R; Loy, Clement; Burrell, Aiden JC; Pellegrini, Breanna; Salimi, Farhad; Begum, Husna; Broadley, Tessa; Campbell, Lewis T; Cheng, Allen C; Cheung, Winston; Cooper, D James; Earnest, Arul; Erickson, Simon J; French, Craig J; Litton, Edward; Murthy, Srinivas; McAllister, Richard; Nichol, Alistair; Palermo, Annamaria; Plummer, Mark; Ramanan, Mahesh; Reddi, Benjamin; Reynolds, Claire; Trapani, Tony; Webb, Steven AR; Udy, Andrew; Hao Tran, Tu; Sasikumar, Suraj Narayanan; Hennessy, Annamarie; O’Loughlin, Aiden; Morgan, Lucy; Blakely, Tony; Thompson, Jason; Carvalho, Natalie; Bablani, Laxman; Wilson, Nick; Stevenson, Mark; Scott, Nick; Palmer, Anna; Delport, Dominic; Abeysuriya, Romesh; Stuart, Robyn; Kerr, Cliff C; Mistry, Dina; Klein, Daniel; Sacks-Davis, Rachel; Heath, Katie; Hainsworth, Samuel
      Published 2020
      Recovery after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains uncertain. A considerable proportion of patients experience persistent symptoms after SARS-CoV-2 infection which impacts ...
      Open Access
      Article
    • The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020 – March 2021 

      Koirala, Archana; Gidding, Heather F; Vette, Kaitlyn; Macartney, Kristine; Wood, Nicholas; Britton, Philip N; Wurzel, Danielle; Marshall, Helen; Clark, Julia E; Wadia, Ushma; Crawford, Nigel W; Richmond, Peter; Bartlett, Adam; Carr, Jeremy; O’Sullivan, Matthew VN; Nicholson, Suellen; Downes, Marnie; Carlin, John; Skowno, Justin; Hannah, Donald; Davidson, Andrew; Ungern‐Sternberg, Britta; Burgoyne, Laura; Archer, Paul‐Lee
      Published 2022
      Article
    • Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020 

      Gidding, Heather F; Machalek, Dorothy A; Hendry, Alexandra J; Quinn, Helen E; Vette, Kaitlyn; Beard, Frank H; Shilling, Hannah S; Hirani, Rena; Gosbell, Iain B; Irving, David O; Hueston, Linda; Downes, Marnie; Carlin, John B; O'Sullivan, Matthew VN; Dwyer, Dominic E; Kaldor, John M; Macartney, Kristine
      Published 2021
      OBJECTIVES: To estimate SARS-CoV-2-specific antibody seroprevalence after the first epidemic wave of coronavirus disease 2019 (COVID-19) in Sydney. SETTING, PARTICIPANTS: People of any age who had provided blood for testing ...
      Article